Haleon plc
Haleon plc (HLNCF) Stock Competitors & Peer Comparison
See (HLNCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLNCF | $4.95 | +4.32% | 44.5B | 23.57 | $0.21 | +1.76% |
| MKKGY | $26.11 | +3.62% | 56.9B | 17.08 | $1.53 | +1.91% |
| MKGAF | $130.35 | +3.08% | 55.2B | 16.53 | $7.68 | +1.97% |
| TKPHF | $27.50 | -3.71% | 44.6B | 49.24 | $0.58 | +4.66% |
| IPSEY | $31.14 | +0.26% | 41.2B | 19.83 | $1.57 | +0.83% |
| SDZNY | $59.31 | +2.36% | 25.5B | 114.04 | $0.52 | +1.14% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | -2.23% | 16.4B | -95.47 | -$0.15 | N/A |
| SGIOY | $9.07 | +1.34% | 15.5B | 13.35 | $0.68 | +1.76% |
| SGIOF | $16.79 | +0.00% | 14.3B | 12.35 | $1.36 | +4.84% |
Stock Comparison
HLNCF vs MKKGY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, MKKGY has a market cap of 56.9B. Regarding current trading prices, HLNCF is priced at $4.95, while MKKGY trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas MKKGY's P/E ratio is 17.08. In terms of profitability, HLNCF's ROE is +0.09%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check MKKGY's competition here
HLNCF vs MKGAF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, MKGAF has a market cap of 55.2B. Regarding current trading prices, HLNCF is priced at $4.95, while MKGAF trades at $130.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas MKGAF's P/E ratio is 16.53. In terms of profitability, HLNCF's ROE is +0.09%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check MKGAF's competition here
HLNCF vs TKPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, HLNCF is priced at $4.95, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TKPHF's P/E ratio is 49.24. In terms of profitability, HLNCF's ROE is +0.09%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, HLNCF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check TKPHF's competition here
HLNCF vs IPSEY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, IPSEY has a market cap of 41.2B. Regarding current trading prices, HLNCF is priced at $4.95, while IPSEY trades at $31.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas IPSEY's P/E ratio is 19.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, HLNCF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check IPSEY's competition here
HLNCF vs SDZNY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SDZNY has a market cap of 25.5B. Regarding current trading prices, HLNCF is priced at $4.95, while SDZNY trades at $59.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SDZNY's P/E ratio is 114.04. In terms of profitability, HLNCF's ROE is +0.09%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SDZNY's competition here
HLNCF vs ESALY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HLNCF is priced at $4.95, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ESALY's competition here
HLNCF vs TEVJF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, HLNCF is priced at $4.95, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, HLNCF's ROE is +0.09%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, HLNCF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check TEVJF's competition here
HLNCF vs SGIOY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SGIOY has a market cap of 15.5B. Regarding current trading prices, HLNCF is priced at $4.95, while SGIOY trades at $9.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SGIOY's P/E ratio is 13.35. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SGIOY's competition here
HLNCF vs SGIOF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, HLNCF is priced at $4.95, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SGIOF's competition here
HLNCF vs BIOVF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, HLNCF is priced at $4.95, while BIOVF trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BIOVF's P/E ratio is 21.95. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, HLNCF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BIOVF's competition here
HLNCF vs IPSEF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, HLNCF is priced at $4.95, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, HLNCF's ROE is +0.09%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, HLNCF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check IPSEF's competition here
HLNCF vs SFOSF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SFOSF has a market cap of 8.8B. Regarding current trading prices, HLNCF is priced at $4.95, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, HLNCF's ROE is +0.09%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SFOSF's competition here
HLNCF vs ESALF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ESALF has a market cap of 8.7B. Regarding current trading prices, HLNCF is priced at $4.95, while ESALF trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ESALF's P/E ratio is 27.93. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ESALF's competition here
HLNCF vs ESAIY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ESAIY has a market cap of 8.6B. Regarding current trading prices, HLNCF is priced at $4.95, while ESAIY trades at $7.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ESAIY's P/E ratio is 27.25. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ESAIY's competition here
HLNCF vs GZPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, HLNCF is priced at $4.95, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, HLNCF's ROE is +0.09%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, HLNCF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check GZPHF's competition here
HLNCF vs HKMPY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HKMPY has a market cap of 5.3B. Regarding current trading prices, HLNCF is priced at $4.95, while HKMPY trades at $51.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HKMPY's P/E ratio is 14.45. In terms of profitability, HLNCF's ROE is +0.09%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, HLNCF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HKMPY's competition here
HLNCF vs HKMPF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HKMPF has a market cap of 5.3B. Regarding current trading prices, HLNCF is priced at $4.95, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HKMPF's P/E ratio is 14.35. In terms of profitability, HLNCF's ROE is +0.09%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HLNCF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HKMPF's competition here
HLNCF vs SGFEF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, HLNCF is priced at $4.95, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SGFEF's P/E ratio is 25.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGFEF's ROE of +0.17%. Regarding short-term risk, HLNCF is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SGFEF's competition here
HLNCF vs WIBFF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, HLNCF is priced at $4.95, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, HLNCF's ROE is +0.09%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to WIBFF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check WIBFF's competition here
HLNCF vs HLBBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HLBBF has a market cap of 4.4B. Regarding current trading prices, HLNCF is priced at $4.95, while HLBBF trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HLBBF's P/E ratio is 10.61. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, HLNCF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HLBBF's competition here
HLNCF vs HLUBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HLUBF has a market cap of 4.3B. Regarding current trading prices, HLNCF is priced at $4.95, while HLUBF trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HLUBF's P/E ratio is 8.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, HLNCF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HLUBF's competition here
HLNCF vs SMDPY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, HLNCF is priced at $4.95, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SMDPY's P/E ratio is 24.38. In terms of profitability, HLNCF's ROE is +0.09%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SMDPY's competition here
HLNCF vs LVZPF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, HLNCF is priced at $4.95, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, HLNCF's ROE is +0.09%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LVZPF's competition here
HLNCF vs CHSYF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, HLNCF is priced at $4.95, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CHSYF's competition here
HLNCF vs ULIHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, HLNCF is priced at $4.95, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, HLNCF's ROE is +0.09%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, HLNCF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ULIHF's competition here
HLNCF vs APNHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, HLNCF is priced at $4.95, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas APNHF's P/E ratio is 12.72. In terms of profitability, HLNCF's ROE is +0.09%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check APNHF's competition here
HLNCF vs INVVY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HLNCF is priced at $4.95, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HLNCF's ROE is +0.09%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, HLNCF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check INVVY's competition here
HLNCF vs IZQVF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HLNCF is priced at $4.95, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HLNCF's ROE is +0.09%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, HLNCF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check IZQVF's competition here
HLNCF vs DNPUF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, HLNCF is priced at $4.95, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check DNPUF's competition here
HLNCF vs LBTSF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, HLNCF is priced at $4.95, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, HLNCF's ROE is +0.09%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, HLNCF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LBTSF's competition here
HLNCF vs APNHY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, HLNCF is priced at $4.95, while APNHY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas APNHY's P/E ratio is 11.37. In terms of profitability, HLNCF's ROE is +0.09%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check APNHY's competition here
HLNCF vs HMDCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, HLNCF is priced at $4.95, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HMDCF's competition here
HLNCF vs HYPMY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HYPMY has a market cap of 2.6B. Regarding current trading prices, HLNCF is priced at $4.95, while HYPMY trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HYPMY's P/E ratio is 18.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, HLNCF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HYPMY's competition here
HLNCF vs THCBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, HLNCF is priced at $4.95, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas THCBF's P/E ratio is -0.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check THCBF's competition here
HLNCF vs DMPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, HLNCF is priced at $4.95, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, HLNCF's ROE is +0.09%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, HLNCF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check DMPHF's competition here
HLNCF vs HTSUF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, HLNCF is priced at $4.95, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HTSUF's P/E ratio is 15.99. In terms of profitability, HLNCF's ROE is +0.09%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, HLNCF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HTSUF's competition here
HLNCF vs CURLF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CURLF has a market cap of 2.1B. Regarding current trading prices, HLNCF is priced at $4.95, while CURLF trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CURLF's P/E ratio is -7.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, HLNCF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check CURLF's competition here
HLNCF vs LJUIF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, HLNCF is priced at $4.95, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, HLNCF's ROE is +0.09%, compared to LJUIF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LJUIF's competition here
HLNCF vs GTBIF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, GTBIF has a market cap of 1.9B. Regarding current trading prices, HLNCF is priced at $4.95, while GTBIF trades at $8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas GTBIF's P/E ratio is 74.27. In terms of profitability, HLNCF's ROE is +0.09%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, HLNCF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check GTBIF's competition here
HLNCF vs CASBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CASBF has a market cap of 1.9B. Regarding current trading prices, HLNCF is priced at $4.95, while CASBF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CASBF's P/E ratio is -29.81. In terms of profitability, HLNCF's ROE is +0.09%, compared to CASBF's ROE of -0.04%. Regarding short-term risk, HLNCF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CASBF's competition here
HLNCF vs ARSUF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, HLNCF is priced at $4.95, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, HLNCF's ROE is +0.09%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, HLNCF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ARSUF's competition here
HLNCF vs TSMRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, HLNCF is priced at $4.95, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TSMRF's P/E ratio is 8.21. In terms of profitability, HLNCF's ROE is +0.09%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, HLNCF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check TSMRF's competition here
HLNCF vs NPNKF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, HLNCF is priced at $4.95, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas NPNKF's P/E ratio is 7.82. In terms of profitability, HLNCF's ROE is +0.09%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, HLNCF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check NPNKF's competition here
HLNCF vs MITPF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HLNCF is priced at $4.95, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HLNCF's ROE is +0.09%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, HLNCF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check MITPF's competition here
HLNCF vs KARBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HLNCF is priced at $4.95, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to KARBF's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check KARBF's competition here
HLNCF vs EVOTF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, HLNCF is priced at $4.95, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas EVOTF's P/E ratio is -6.22. In terms of profitability, HLNCF's ROE is +0.09%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, HLNCF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check EVOTF's competition here
HLNCF vs NPPNY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, HLNCF is priced at $4.95, while NPPNY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas NPPNY's P/E ratio is 6.55. In terms of profitability, HLNCF's ROE is +0.09%, compared to NPPNY's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check NPPNY's competition here
HLNCF vs SHEZF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, HLNCF is priced at $4.95, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HLNCF's ROE is +0.09%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SHEZF's competition here
HLNCF vs TCNNF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TCNNF has a market cap of 1.4B. Regarding current trading prices, HLNCF is priced at $4.95, while TCNNF trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TCNNF's P/E ratio is -9.09. In terms of profitability, HLNCF's ROE is +0.09%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, HLNCF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check TCNNF's competition here
HLNCF vs CHIZF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, HLNCF is priced at $4.95, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, HLNCF's ROE is +0.09%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CHIZF's competition here
HLNCF vs KSPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, HLNCF is priced at $4.95, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, HLNCF's ROE is +0.09%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check KSPHF's competition here
HLNCF vs GNMLF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, HLNCF is priced at $4.95, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, HLNCF's ROE is +0.09%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, HLNCF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check GNMLF's competition here
HLNCF vs SWGHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, HLNCF is priced at $4.95, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, HLNCF's ROE is +0.09%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, HLNCF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SWGHF's competition here
HLNCF vs KKPCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, KKPCF has a market cap of 1.1B. Regarding current trading prices, HLNCF is priced at $4.95, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, HLNCF's ROE is +0.09%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check KKPCF's competition here
HLNCF vs BIOGY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BIOGY has a market cap of 995.4M. Regarding current trading prices, HLNCF is priced at $4.95, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BIOGY's P/E ratio is 32.53. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, HLNCF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BIOGY's competition here
HLNCF vs NIKA Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, NIKA has a market cap of 972.7M. Regarding current trading prices, HLNCF is priced at $4.95, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas NIKA's P/E ratio is N/A. In terms of profitability, HLNCF's ROE is +0.09%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, HLNCF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check NIKA's competition here
HLNCF vs SHPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, HLNCF is priced at $4.95, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, HLNCF's ROE is +0.09%, compared to SHPHF's ROE of -0.05%. Regarding short-term risk, HLNCF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SHPHF's competition here
HLNCF vs LVTTF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LVTTF has a market cap of 890.3M. Regarding current trading prices, HLNCF is priced at $4.95, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to LVTTF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LVTTF's competition here
HLNCF vs EVRRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, EVRRF has a market cap of 886.5M. Regarding current trading prices, HLNCF is priced at $4.95, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, HLNCF's ROE is +0.09%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, HLNCF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check EVRRF's competition here
HLNCF vs NRXCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, NRXCF has a market cap of 841.1M. Regarding current trading prices, HLNCF is priced at $4.95, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, HLNCF's ROE is +0.09%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, HLNCF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check NRXCF's competition here
HLNCF vs TWAPF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, HLNCF is priced at $4.95, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, HLNCF's ROE is +0.09%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, HLNCF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check TWAPF's competition here
HLNCF vs CSWYF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, HLNCF is priced at $4.95, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, HLNCF's ROE is +0.09%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CSWYF's competition here
HLNCF vs TRXPF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, HLNCF is priced at $4.95, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HLNCF's ROE is +0.09%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check TRXPF's competition here
HLNCF vs YIHCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, HLNCF is priced at $4.95, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check YIHCF's competition here
HLNCF vs ELTP Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ELTP has a market cap of 608.2M. Regarding current trading prices, HLNCF is priced at $4.95, while ELTP trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ELTP's P/E ratio is -28.40. In terms of profitability, HLNCF's ROE is +0.09%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, HLNCF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ELTP's competition here
HLNCF vs TRSSF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HLNCF is priced at $4.95, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HLNCF's ROE is +0.09%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, HLNCF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check TRSSF's competition here
HLNCF vs SWDCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, SWDCF has a market cap of 600.2M. Regarding current trading prices, HLNCF is priced at $4.95, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas SWDCF's P/E ratio is 93.88. In terms of profitability, HLNCF's ROE is +0.09%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HLNCF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check SWDCF's competition here
HLNCF vs AIHLF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, HLNCF is priced at $4.95, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check AIHLF's competition here
HLNCF vs PKBFF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, HLNCF is priced at $4.95, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HLNCF's ROE is +0.09%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HLNCF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check PKBFF's competition here
HLNCF vs CCHWF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HLNCF is priced at $4.95, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HLNCF's ROE is +0.09%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, HLNCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check CCHWF's competition here
HLNCF vs GLASF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, GLASF has a market cap of 485.7M. Regarding current trading prices, HLNCF is priced at $4.95, while GLASF trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas GLASF's P/E ratio is -76.44. In terms of profitability, HLNCF's ROE is +0.09%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, HLNCF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check GLASF's competition here
HLNCF vs KHTRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, HLNCF is priced at $4.95, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, HLNCF's ROE is +0.09%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, HLNCF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check KHTRF's competition here
HLNCF vs PEXXF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HLNCF is priced at $4.95, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check PEXXF's competition here
HLNCF vs VRNOF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, VRNOF has a market cap of 450.4M. Regarding current trading prices, HLNCF is priced at $4.95, while VRNOF trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas VRNOF's P/E ratio is -1.26. In terms of profitability, HLNCF's ROE is +0.09%, compared to VRNOF's ROE of -0.26%. Regarding short-term risk, HLNCF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check VRNOF's competition here
HLNCF vs BOIRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BOIRF has a market cap of 416.7M. Regarding current trading prices, HLNCF is priced at $4.95, while BOIRF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BOIRF's P/E ratio is 31.58. In terms of profitability, HLNCF's ROE is +0.09%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BOIRF's competition here
HLNCF vs AGYTF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, HLNCF is priced at $4.95, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, HLNCF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check AGYTF's competition here
HLNCF vs HUMDF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, HLNCF is priced at $4.95, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, HLNCF's ROE is +0.09%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, HLNCF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HUMDF's competition here
HLNCF vs CRLBF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CRLBF has a market cap of 320.9M. Regarding current trading prices, HLNCF is priced at $4.95, while CRLBF trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CRLBF's P/E ratio is -6.79. In terms of profitability, HLNCF's ROE is +0.09%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, HLNCF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check CRLBF's competition here
HLNCF vs CPHRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CPHRF has a market cap of 279.3M. Regarding current trading prices, HLNCF is priced at $4.95, while CPHRF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CPHRF's P/E ratio is 30.28. In terms of profitability, HLNCF's ROE is +0.09%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CPHRF's competition here
HLNCF vs BHCCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, HLNCF is priced at $4.95, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HLNCF's ROE is +0.09%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, HLNCF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BHCCF's competition here
HLNCF vs BIOIF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BIOIF has a market cap of 204.2M. Regarding current trading prices, HLNCF is priced at $4.95, while BIOIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, HLNCF is more volatile compared to BIOIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BIOIF's competition here
HLNCF vs PLNHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HLNCF is priced at $4.95, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, HLNCF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check PLNHF's competition here
HLNCF vs PHCUF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, PHCUF has a market cap of 156.6M. Regarding current trading prices, HLNCF is priced at $4.95, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas PHCUF's P/E ratio is -293.74. In terms of profitability, HLNCF's ROE is +0.09%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, HLNCF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check PHCUF's competition here
HLNCF vs CBWTF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CBWTF has a market cap of 154.4M. Regarding current trading prices, HLNCF is priced at $4.95, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CBWTF's P/E ratio is 5.75. In terms of profitability, HLNCF's ROE is +0.09%, compared to CBWTF's ROE of +0.20%. Regarding short-term risk, HLNCF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check CBWTF's competition here
HLNCF vs PLNH Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, PLNH has a market cap of 149.7M. Regarding current trading prices, HLNCF is priced at $4.95, while PLNH trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas PLNH's P/E ratio is -3.29. In terms of profitability, HLNCF's ROE is +0.09%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, HLNCF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check PLNH's competition here
HLNCF vs JUSHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, JUSHF has a market cap of 135.7M. Regarding current trading prices, HLNCF is priced at $4.95, while JUSHF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas JUSHF's P/E ratio is -2.30. In terms of profitability, HLNCF's ROE is +0.09%, compared to JUSHF's ROE of +1.20%. Regarding short-term risk, HLNCF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check JUSHF's competition here
HLNCF vs COPHF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HLNCF is priced at $4.95, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HLNCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check COPHF's competition here
HLNCF vs AAWH Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, AAWH has a market cap of 130.7M. Regarding current trading prices, HLNCF is priced at $4.95, while AAWH trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas AAWH's P/E ratio is -1.53. In terms of profitability, HLNCF's ROE is +0.09%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, HLNCF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check AAWH's competition here
HLNCF vs LOVFF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LOVFF has a market cap of 127.1M. Regarding current trading prices, HLNCF is priced at $4.95, while LOVFF trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LOVFF's P/E ratio is 11.58. In terms of profitability, HLNCF's ROE is +0.09%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LOVFF's competition here
HLNCF vs STMH Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, STMH has a market cap of 125.7M. Regarding current trading prices, HLNCF is priced at $4.95, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas STMH's P/E ratio is N/A. In terms of profitability, HLNCF's ROE is +0.09%, compared to STMH's ROE of -2.75%. Regarding short-term risk, HLNCF is more volatile compared to STMH. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check STMH's competition here
HLNCF vs NWPN Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, HLNCF is priced at $4.95, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas NWPN's P/E ratio is -0.04. In terms of profitability, HLNCF's ROE is +0.09%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HLNCF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.Check NWPN's competition here
HLNCF vs GRUSF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, GRUSF has a market cap of 117.4M. Regarding current trading prices, HLNCF is priced at $4.95, while GRUSF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas GRUSF's P/E ratio is -15.79. In terms of profitability, HLNCF's ROE is +0.09%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, HLNCF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check GRUSF's competition here
HLNCF vs HLTRF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, HLTRF has a market cap of 116.2M. Regarding current trading prices, HLNCF is priced at $4.95, while HLTRF trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas HLTRF's P/E ratio is -6.49. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, HLNCF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check HLTRF's competition here
HLNCF vs LPCUF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, HLNCF is priced at $4.95, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, HLNCF's ROE is +0.09%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LPCUF's competition here
HLNCF vs CNVCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HLNCF is priced at $4.95, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to CNVCF's ROE of -3.90%. Regarding short-term risk, HLNCF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check CNVCF's competition here
HLNCF vs BIOYF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, BIOYF has a market cap of 95.1M. Regarding current trading prices, HLNCF is priced at $4.95, while BIOYF trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas BIOYF's P/E ratio is 17.27. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, HLNCF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check BIOYF's competition here
HLNCF vs LRDSF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, LRDSF has a market cap of 83.9M. Regarding current trading prices, HLNCF is priced at $4.95, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, HLNCF's ROE is +0.09%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, HLNCF is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check LRDSF's competition here
HLNCF vs ABSCF Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, ABSCF has a market cap of 80.3M. Regarding current trading prices, HLNCF is priced at $4.95, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, HLNCF's ROE is +0.09%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, HLNCF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check ABSCF's competition here
HLNCF vs EOFBY Comparison August 2025
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 44.5B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, HLNCF is priced at $4.95, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 23.57, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, HLNCF's ROE is +0.09%, compared to EOFBY's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.Check EOFBY's competition here